|
Market Closed -
Nasdaq Stockholm
09:30:00 30/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 33.40 SEK | +3.09% |
|
-1.76% | +4.54% |
| 29/09 | C-Rad and SeeTreat develop joint platform for radiation therapy | FW |
| 29/09 | C-Rad enters partnership with SeeTreat | FW |
Business description: C-Rad AB
Number of employees: 98
Sales by Activity: C-Rad AB
| Fiscal Period: December | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) | 2025 (SEK) |
|---|---|---|---|---|---|
Positioning | 26Cr | 30Cr | 42Cr | 47Cr | 44Cr |
Geographical breakdown of sales: C-Rad AB
| Fiscal Period: December | 2021 (SEK) | 2022 (SEK) | 2023 (SEK) | 2024 (SEK) | 2025 (SEK) |
|---|---|---|---|---|---|
EMEA (Excluding Sweden) | - | - | - | - | 17Cr |
APAC | - | - | 12Cr | 21Cr | 17Cr |
Americas | - | - | 8.6Cr | 7.27Cr | 9.88Cr |
Sweden | 2.17Cr | 86.66L | - | - | 85.69L |
South and Latin America | 7L | 7L | - | - | - |
Dach (Germany, Austria, Switzerland) | 4.06Cr | 3.19Cr | - | - | - |
The Rest of The Nordic Countries | 53.71L | 1.21Cr | - | - | - |
EMEA | - | - | 22Cr | 19Cr | - |
France | 1.39Cr | 1.53Cr | - | - | - |
ROE (Other Europe) | 4.63Cr | 7.8Cr | - | - | - |
Asia | 8.21Cr | 8.4Cr | - | - | - |
USA | 5.06Cr | 7.08Cr | - | - | - |
Executive Committee: C-Rad AB
| Manager | Title | Age | Since |
|---|---|---|---|
Tomas Blomquist
CEO | Chief Executive Officer | 56 | 02/02/2026 |
Linda Frölén
CEO | Chief Executive Officer | 49 | 21/10/2025 |
| Chief Tech/Sci/R&D Officer | - | - | |
Johan Danielsson
COO | Chief Operating Officer | 50 | - |
Andreas Juhlin
PRN | Corporate Officer/Principal | 52 | 01/04/2026 |
Composition of the Board of Directors: C-Rad AB
| Director | Title | Age | Since |
|---|---|---|---|
David Sjöström
BRD | Director/Board Member | 52 | 01/01/2017 |
| Director/Board Member | 60 | 07/05/2021 | |
| Chairman | 61 | 05/05/2023 | |
| Director/Board Member | 60 | 05/05/2023 | |
| Director/Board Member | 66 | 05/05/2023 | |
| Director/Board Member | 55 | 23/07/2007 |
Holdings: C-Rad AB
| Name | Stocks | % | Valuation |
|---|---|---|---|
C-RAD AB 2.39% | 7,85,500 | 2.39% | 3 M $ |
Company details: C-Rad AB
Other Advanced Medical Equipment & Technology
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.09% | -1.76% | +8.44% | +10.96% | 11Cr | |
| -0.67% | +2.51% | +46.10% | +33.36% | 25TCr | |
| -1.84% | +0.21% | +19.07% | -10.70% | 16TCr | |
| -1.35% | +1.13% | -7.42% | +39.12% | 15TCr | |
| -0.52% | -2.83% | -55.02% | -17.33% | 6.36TCr | |
| -2.00% | -2.77% | +11.83% | +24.60% | 5.08TCr | |
| -1.55% | +3.02% | +39.24% | +54.10% | 4.93TCr | |
| -1.76% | +1.44% | -16.73% | -20.90% | 4.87TCr | |
| +2.47% | +9.41% | -2.58% | +40.30% | 4.51TCr | |
| -0.87% | +3.21% | +51.81% | +60.24% | 4.35TCr | |
| Average | -0.32% | +2.42% | +9.48% | +21.38% | 8.57TCr | |
| Weighted average by Cap. | -0.58% | +3.06% | +16.22% | +21.72% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRAD B Stock
- Company C-Rad AB
Select your edition
All financial news and data tailored to specific country editions
